SHBG: How to Interpret Your Result

What Is SHBG and Why Does It Matter?

Sex hormone-binding globulin is a glycoprotein produced primarily in the liver. It circulates in the blood and binds testosterone and estradiol with high affinity, binding dihydrotestosterone (DHT) with the highest affinity of all three. Only the hormone that is not bound to SHBG, or loosely bound to albumin, can enter cells and activate receptors. That fraction is what clinicians mean by "bioavailable" or "free" hormone.

Most routine testosterone panels report total testosterone, which includes hormone bound to SHBG and albumin as well as the free fraction. Two people with identical total testosterone values can have dramatically different free testosterone concentrations if their SHBG levels differ. This is why your SHBG number can change the clinical meaning of an otherwise unremarkable testosterone result.

Why the Liver Matters Here

The liver is SHBG's main production site. Anything that impairs hepatic function, including fatty liver disease, cirrhosis, or chronic alcohol use, tends to lower SHBG output. Conversely, conditions that up-regulate hepatic protein synthesis, such as hyperthyroidism or oral estrogen therapy, raise SHBG. The Endocrine Society's 2018 guideline on testosterone therapy notes that oral estrogens increase SHBG substantially more than transdermal preparations, a difference with real clinical consequences for free-hormone calculations. [1]

SHBG as a Metabolic Marker

Beyond sex hormone physiology, SHBG functions as an independent metabolic signal. A 2010 prospective study published in the New England Journal of Medicine (N=1,129 women followed 7.4 years) found that each standard-deviation decrease in SHBG was associated with a roughly 80% increase in the odds of developing type 2 diabetes, independent of total testosterone and BMI. [2] Low SHBG is now recognized by the American Diabetes Association as part of the metabolic risk cluster for insulin resistance. [3]

Normal SHBG Ranges by Age and Sex

Reference intervals vary by laboratory and assay, but widely used clinical ranges from the Mayo Clinic and published literature are as follows.

Men

| Age Group | SHBG Reference Range | |---|---| | 20 to 49 years | 16 to 74 nmol/L | | 50 to 69 years | 20 to 90 nmol/L | | 70+ years | 30 to 120 nmol/L |

SHBG rises steadily with age in men, roughly 1 to 2% per year after age 40. [4] That physiological increase is one reason why aging men frequently report symptoms of low testosterone despite total testosterone levels that appear normal on paper: rising SHBG is sequestering more of whatever testosterone is produced.

Women

| Reproductive Status | SHBG Reference Range | |---|---| | Premenopausal (mid-cycle) | 32 to 128 nmol/L | | Postmenopausal (no HRT) | 18 to 90 nmol/L | | Postmenopausal (oral estrogen) | Can exceed 200 nmol/L |

Women using combined oral contraceptives can see SHBG levels rise three- to fourfold above baseline because of the ethinyl estradiol component. [5] This suppression of free testosterone is one mechanism proposed to explain decreased libido reported by some OCP users even after discontinuation.

Children and Adolescents

SHBG is markedly elevated in prepubertal children, often exceeding 200 nmol/L, and falls sharply during puberty as rising androgens suppress hepatic SHBG production. Pediatric interpretation requires age- and Tanner-stage-specific reference intervals; adult cut-offs do not apply.

What Does a High SHBG Mean?

A high SHBG result means that more of your circulating sex hormones are bound and therefore unavailable to tissues. The clinical impact depends on whether the elevation is causing symptoms.

Common Causes of Elevated SHBG

• Hyperthyroidism. Thyroid hormone directly stimulates SHBG gene transcription. Patients with uncontrolled Graves disease often have SHBG values two to three times the upper reference limit. [6]
• Oral estrogen therapy or combined oral contraceptives. Oral estrogen bypasses hepatic first-pass metabolism differently than transdermal estrogen and substantially up-regulates SHBG synthesis. Transdermal 17-beta-estradiol at standard doses (0.05 to 0.1 mg/day patch) raises SHBG by roughly 20 to 30%, compared with 200 to 400% for equivalent oral doses. [1]
• Cirrhosis and chronic hepatitis. The mechanism here is paradoxical: despite impaired liver function, inflammatory cytokines and altered hormone clearance in cirrhosis tend to raise SHBG. [7]
• Anorexia nervosa and severe caloric restriction. Low insulin and IGF-1 during starvation remove the primary physiological brake on SHBG synthesis.
• Aging. As noted above, SHBG rises approximately 1 to 2% per year in men after age 40. [4]
• HIV and antiretroviral therapy. Certain protease inhibitors raise SHBG, complicating testosterone assessment in men with HIV.

Symptoms Linked to High SHBG

High SHBG itself causes no direct symptoms; the symptoms arise from low free hormone levels. Men may report low libido, poor erections, fatigue, and loss of muscle mass. Women may report reduced libido, mood changes, and vaginal dryness. These symptoms overlap significantly with other conditions, so SHBG elevation alone is not sufficient to justify treatment without a full clinical picture.

How High Is Too High?

The Endocrine Society does not publish a universal "too-high" threshold for SHBG in isolation. The clinical decision point is low calculated free testosterone combined with symptoms, not the SHBG value alone. The Vermeulen equation, using total testosterone, SHBG, and an assumed albumin of 4.3 g/dL, remains the most widely validated method for estimating free testosterone without expensive direct assay. [8]

What Does a Low SHBG Mean?

Low SHBG raises the free fraction of both testosterone and estradiol. This is not always a problem, but it can signal metabolic dysfunction and, in women, may contribute to androgen-excess conditions.

Common Causes of Low SHBG

• Insulin resistance and obesity. Hyperinsulinemia suppresses hepatic SHBG production. This is the most common cause of low SHBG in clinical practice. [2]
• Polycystic ovary syndrome (PCOS). Low SHBG amplifies the impact of mildly elevated androgens in PCOS, worsening hirsutism and acne. The Endocrine Society's 2018 PCOS guideline lists free androgen index (FAI = total testosterone x 100 / SHBG) as a useful surrogate marker for free testosterone. [9]
• Hypothyroidism. Low thyroid hormone reduces SHBG transcription, the mirror image of hyperthyroidism.
• Exogenous androgen use. Testosterone therapy, anabolic steroids, and DHEA supplementation all suppress SHBG, sometimes to single-digit levels.
• Type 2 diabetes. A 2013 meta-analysis in Diabetes Care (pooling data from 20 prospective studies, N=25,827) found that the lowest SHBG quartile carried more than twice the risk of incident type 2 diabetes compared with the highest quartile (RR 2.44, 95% CI 1.91 to 3.12, P<0.001). [3]
• Nephrotic syndrome. Urinary loss of proteins including SHBG lowers circulating levels.

When Low SHBG Is Clinically Significant in Women

In premenopausal women with signs of androgen excess (hirsutism, irregular cycles, acne), a free androgen index above 4.5 alongside low SHBG warrants evaluation for PCOS or adrenal androgen excess per Endocrine Society criteria. [9] Low SHBG in postmenopausal women on oral estrogen may suggest insufficient estrogenic up-regulation, which could reflect non-adherence or absorption issues.

When Low SHBG Is Clinically Significant in Men

In men, the main concern with very low SHBG (below 12 to 14 nmol/L in most labs) is an elevated free testosterone combined with total testosterone in the normal range. This is seen with obesity-related hypogonadotropic hypogonadism, where total testosterone looks borderline but free testosterone may be adequate. In this scenario, weight loss rather than testosterone replacement is the recommended first-line intervention per the 2018 Endocrine Society guideline. [1]

How to Calculate Free Testosterone from Your SHBG Result

Direct free testosterone immunoassays are widely considered unreliable at low concentrations. The 2018 Endocrine Society guideline specifically recommends against using direct free testosterone assays in routine clinical practice and instead endorses calculated free testosterone using the Vermeulen equation or equilibrium dialysis reference method. [1]

The Vermeulen Equation in Practice

The inputs are:

1. Total testosterone (nmol/L or convert from ng/dL by dividing by 28.85)
2. SHBG (nmol/L)
3. Albumin (assumed 4.3 g/dL unless measured)

Free calculators based on the Vermeulen method are available through the International Society for the Study of the Aging Male (ISSAM). A free testosterone below 65 pg/mL (225 pmol/L) in a symptomatic man is generally considered consistent with androgen deficiency, though the Endocrine Society does not endorse a single numeric threshold in its current guidelines. [1]

The Free Androgen Index

The free androgen index (FAI) is a simpler surrogate: FAI = (total testosterone in nmol/L x 100) / SHBG in nmol/L. Values above 4.5 in women suggest androgen excess. FAI is less accurate than the Vermeulen calculation but useful when only total testosterone and SHBG are available. [9]

How to Lower SHBG When It Is Too High

Reducing SHBG is rarely a direct treatment target; the goal is typically to treat the underlying cause. Several interventions reliably lower SHBG.

Treat the Root Cause First

Correcting hyperthyroidism with methimazole or radioactive iodine will normalize SHBG within weeks of achieving euthyroid status. Switching from oral to transdermal estradiol (for example, from 1 mg oral estradiol to a 0.05 mg/day patch) can reduce SHBG by 40 to 60% in menopausal women. [1]

Lifestyle Interventions

Resistance training three to five days per week reduces SHBG modestly. A 12-week randomized trial in older men (N=40) found that combined resistance and aerobic training reduced SHBG by a mean of 8.2 nmol/L (P<0.01) alongside a 12% increase in free testosterone. [10] Reducing alcohol consumption is also worthwhile; chronic alcohol use raises SHBG even in the absence of overt liver disease.

Pharmacologic Options

Danazol, a synthetic androgen, reliably suppresses SHBG but carries significant side-effect concerns (androgenic effects, hepatotoxicity) and is rarely used outside specific indications such as hereditary angioedema. Low-dose testosterone therapy in hypogonadal men suppresses SHBG as a secondary effect. Stanozolol, which appears in older literature as a potent SHBG suppressor, is not approved for this indication and carries serious cardiovascular risks.

How to Raise SHBG When It Is Too Low

Again, addressing the underlying driver is the correct first step before trying to raise SHBG directly.

Weight Loss and Insulin Sensitization

Because hyperinsulinemia is the most common suppressor of SHBG, interventions that lower insulin levels reliably raise SHBG. A 10% reduction in body weight in obese adults typically increases SHBG by 20 to 30%. [2] GLP-1 receptor agonists such as semaglutide (Ozempic/Wegovy) appear to raise SHBG partly through insulin sensitization and partly through direct weight loss; a 2022 analysis of the STEP-1 trial (N=1,961) noted favorable changes in sex hormone profiles alongside the 14.9% mean weight loss at 68 weeks, though SHBG was not a pre-specified endpoint. [11]

Dietary Factors

A higher-fiber, lower-glycemic diet raises SHBG in insulin-resistant individuals. A 2011 trial published in the European Journal of Clinical Nutrition found that substituting white bread with whole-grain bread for 12 weeks raised SHBG by 6.1 nmol/L in overweight premenopausal women (N=96, P<0.05). [12]

Oral Estrogen in Specific Populations

For postmenopausal women where very low SHBG contributes to androgen-excess symptoms from relatively higher free testosterone, switching to or initiating oral estradiol (rather than transdermal) raises SHBG substantially and reduces free androgen burden. This strategy is mentioned in the ACOG Practice Bulletin on menopausal hormone therapy as a consideration for managing PCOS-like hyperandrogenism in postmenopause. [13]

SHBG and Hormone Replacement Therapy: Key Decision Points

When a patient on testosterone or estrogen therapy presents with a new or worsening SHBG result, the clinical decision flow below describes how most Endocrine Society-aligned practices approach it.

Scenario 1. Man on testosterone therapy, SHBG rises above 60 nmol/L despite adequate total T. Check thyroid function and liver enzymes. If both are normal, the rise may reflect the trough effect of injectable testosterone (levels drawn too close to next injection). Consider shortening injection interval or switching to daily transdermal application to smooth peaks. Reassess SHBG 6 weeks after any dose change.

Scenario 2. Woman on combined oral contraceptive, SHBG above 150 nmol/L, reports low libido. Consider switching to a progestin-dominant pill with less estrogenic activity (such as a 20-mcg ethinyl estradiol formulation with levonorgestrel) or transitioning to a non-hormonal or progestin-only method. Allow 3 to 6 months for SHBG to return toward baseline after stopping the OCP, as post-pill SHBG suppression is slow. [5]

Scenario 3. Man with obesity, SHBG below 15 nmol/L, total T 280 ng/dL, no symptoms. Calculated free testosterone may still be normal or high-normal. Weight loss is the first intervention. Testosterone replacement in this scenario risks further SHBG suppression, worsening insulin resistance markers, and suppressing LH/FSH with consequent fertility impairment. The 2018 Endocrine Society guideline on male hypogonadism explicitly advises against initiating testosterone therapy when weight loss alone might normalize free testosterone. [1]

Ordering the Right Tests Alongside SHBG

SHBG ordered in isolation provides limited information. Ordering it alongside total testosterone (and ideally estradiol in women) allows free hormone calculation. The full androgen panel recommended by the Endocrine Society for initial hypogonadism evaluation includes: [1]

• Total testosterone (8:00 to 10:00 AM fasting sample on two separate days if low-normal)
• SHBG
• LH and FSH (to distinguish primary from secondary hypogonadism)
• Prolactin (if LH/FSH are low)
• Complete metabolic panel including albumin
• Thyroid-stimulating hormone (TSH)

Reporting your results without the companion tests is like reading the numerator of a fraction without the denominator. A single SHBG number means something different depending on total testosterone, clinical symptoms, and metabolic background.

Special Populations: What Standard Ranges Miss

Transgender Women

Transgender women initiating feminizing hormone therapy with estradiol typically see SHBG rise significantly, particularly on oral estradiol. This reduces free testosterone toward the cisgender female reference range, which is often the desired clinical outcome. The Endocrine Society's 2017 guideline on transgender hormone therapy recommends monitoring total testosterone and SHBG together to confirm suppression to the female reference range (below 50 ng/dL total T). [14]

Transgender Men

Testosterone therapy in transgender men suppresses SHBG, sometimes to levels seen in hypogonadal cis men (below 15 nmol/L). Monitoring free testosterone rather than total testosterone may give a more accurate picture of androgen exposure in this context.

Older Adults

The EMAS (European Male Ageing Study), a multicenter cohort of 3,369 men aged 40 to 79, found that rising SHBG with age is the primary driver of the decline in free testosterone that correlates with sexual symptoms, even when total testosterone remains stable. [4] In men over 65, calculating free testosterone from SHBG and total T is more clinically informative than relying on total T alone, per Endocrine Society guidance. [1]